Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events have?
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events has 505 citations in the OpenAlex counts ScholarIQ stores.
When was Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events published?
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events has 2017 year in the ScholarIQ index.
What is the open-access status of Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events?
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events has hybrid oa status in the ScholarIQ index.
What is the DOI of Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events?
The DOI for Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events is on the source record.
What is the PMID of Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events?
The PMID for Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events is on the source record.
What is the OpenAlex record for Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events?
The OpenAlex for Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events is on the source record.